Skip to main content
SL

Sling Therapeutics

Ann Arbor, United States
Last funding
$123.0M
Series CSep 2026

Sling Therapeutics develops pharmaceutical treatments for thyroid eye disease, a condition that can affect tissues surrounding the eyes.

Backed byTPGForbion Capital PartnersThe Rise FundSectoral Asset Management

About Sling Therapeutics

How much funding has Sling Therapeutics raised?

Sling Therapeutics has raised $123.0M in total funding. The most recent round was Series C. The last funding was announced in September 2026.

Who are Sling Therapeutics's investors?

Sling Therapeutics's investors include TPG, Forbion Capital Partners, The Rise Fund, Sectoral Asset Management.

Where is Sling Therapeutics headquartered?

Sling Therapeutics is headquartered in Ann Arbor, United States.

What does Sling Therapeutics do?

Sling Therapeutics develops pharmaceutical treatments for thyroid eye disease, a condition that can affect tissues surrounding the eyes.

What stage is Sling Therapeutics at?

Sling Therapeutics is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Sling Therapeutics — Funding & Investors." VCBacked, September 16, 2026, https://www.vcbacked.co/company/sling-therapeutics. Accessed November 15, 2026.
APA
VCBacked. (2026). Sling Therapeutics — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/sling-therapeutics
Wikipedia (cite web)
{{cite web |title=Sling Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/sling-therapeutics |website=VCBacked |access-date=November 15, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Sling Therapeutics? Request a listing update

Founder contacts
m***@slingtx.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →